The latest thought leadership from our expert teams

Active filters (1)
スケールダウンしたモデル化による堅牢なバイオプロセスの構築
eBook

Creating robust bioprocessing scale-down models

May 18, 2021

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • Bioinnovation
Whitepaper

Building the business of biodesign

Mar 27, 2018

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Strategic advice
The future of farming is biologics
Opinion

Biologics are the future for agriculture, but collaboration will drive commercial development and success

Mar 29, 2023

With transformative opportunities in biological products and sustainable biofuels on the horizon, the agritech industry needs to work together to achieve commercial success and realize environmental advantages. Fresh from his visit to the World Agri-Tech Innovation Summit in San Francisco, Niall Mottram calls for actions to back up the promising rhetoric...

  • AI & Analytics
  • Bioinnovation
  • Sensing
  • Sustainability
Bioprocessing engineering - digital twins in cultured protein scale up
Opinion

How digital twins can help confront the challenges of scaling up cultured protein

Mar 9, 2023

In the world of bioprocessing engineering, companies developing cultured meat and other cultured ingredients face both technical and financial challenges at each step up in scale. Here, Steve Thomas and James Westley explain how sophisticated predictive models – digital twins – that couple biology, heat transfer, mass transfer and fluid dynamics can help… 

  • AI & Analytics
  • Bioinnovation
  • Digital service innovation
  • Fluids & thermodynamics
  • Synthetic biology
Bioprocessing meets machine learning
Opinion

Bioprocessing meets machine learning: the conversation that is driving a cell therapy breakthrough

Mar 8, 2023

A meeting of minds - AI meets biology. This is the conversation that is bridging the gap between bioprocessing and machine learning.

  • AI & Analytics
  • Bioinnovation
  • Cell and gene therapy
  • Synthetic biology
What next for smart implantable medical devices?
Opinion

What next for smart implants?

Feb 20, 2023

The future of smart implantable medical devices – Our experts share key insights for medical implant manufacturers.

  • AI & Analytics
  • Bioinnovation
  • Digital health
Women in STEM
Opinion

My career journey as a woman in STEM

Jan 25, 2023

Being a woman in STEM is something I am proud of. Subjects such as science, technology, engineering, and mathematics (STEM) have always been a huge passion of mine – and so working at a company like Cambridge Consultants that has been at the forefront of innovative development for over 60 years is perfect for me.

  • Bioinnovation
  • Cell and gene therapy
Medtech Innovator Asia Pacific 2022 finalists
Opinion

Six innovative Asia medtech start-ups to watch

Oct 20, 2022

Asia’s medical technology market is predicted to account for a third of global medical technology sales by 2025. As such, it's a hotbed for start-ups, so here are our six innovative start-ups to watch that are part of this year’s MedTech Innovator cohort. 

  • Bioinnovation
  • Cell and gene therapy
  • Digital health
  • Innovation management
  • User Experience (UX)
biological cells
Opinion

How ‘cell mechanomics’ can empower drug discoveries, cell therapies and precision cancer medicine

Sep 7, 2022

Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. It is a biomarker that Cell4D is using to screen and sort live cells

  • Bioinnovation
  • Cell and gene therapy
  • Synthetic biology
The future of drug delivery lies in collaboration
Opinion

Collaboration is the key to unlocking a successful connected future for global pharma

Sep 5, 2022

Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.

  • Bioinnovation
  • Digital health
  • Human factors
  • User Experience (UX)
start-up risk assessment
Opinion

Start-up technology can be risky business if threats aren’t tackled hard and early

Aug 19, 2022

Founders of early-stage start-ups are characteristically passionate, driven and optimistic. Understandably so. Very often they are nurturing a breakthrough idea with the capacity to disrupt business and change the world for the better. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong. 

  • AI & Analytics
  • Bioinnovation
  • Cell and gene therapy
  • Connectivity & IoT
  • Innovation management
  • Project management
  • Robotics
  • Strategic advice
  • Synthetic biology
Medtech Innovator APAC 2022
Opinion

MedTech Innovator is not a one-off, start-up nurturing is in our DNA

Aug 16, 2022

Yan Lin Lye and a team from CC are embarking on a sequence of mentoring sessions as part of our commitment to MedTech Innovator Asia Pacific. For the second consecutive year, we're collaborating with the organisation to provide hands-on professional support to selected start-up participants.

  • Bioinnovation
  • Cell and gene therapy
  • Strategic advice
  • Synthetic biology